Coverage
-
May 05, 2026
Entities representing groups of opioid claimants in the Chapter 11 case of Purdue Pharma have named their representatives on an oversight board created to implement a public repository of documents related to the national opioid epidemic and Purdue's role in the crisis.
213 other articles on this case.
View all »